Literature DB >> 8557964

Alterations in intracellular cations and cell membrane ATPase activity in patients with malignant hypertension.

R M Touyz1, F J Milne.   

Abstract

OBJECTIVE: To determine whether cellular cation concentrations and cell membrane ATPase activity are altered in patients with malignant hypertension.
DESIGN: Sixteen black patients with malignant hypertension were studied and compared with age- and sex-matched essential hypertensive and normotensive subjects. Calcium, magnesium, sodium and potassium concentrations and cell membrane Na,K-ATPase, Ca-ATPase and Mg-ATPase activities were determined in platelets and erythrocytes.
METHODS: Intracellular concentrations of total magnesium and calcium were measured by atomic absorption spectrophotometry, and those of sodium and potassium by flame photometry. Cell membrane ATPase activity was measured by a colorimetric method.
RESULTS: The intracellular calcium level was significantly elevated and intracellular magnesium and potassium levels and cell membrane ATPase activity significantly decreased in the hypertensive group. These changes were more marked in patients with malignant hypertension than in patients with benign essential hypertension. In the malignant hypertensive group, mean arterial pressure was negatively correlated with intracellular magnesium and positively correlated with intracellular calcium and sodium levels.
CONCLUSIONS: Cellular cation changes in malignant hypertension may be related to altered transmembrane transport mechanisms and activation of the renin-angiotensin system. These alterations may be more pronounced in the malignant than in the benign phase of hypertension.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8557964     DOI: 10.1097/00004872-199508000-00007

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  7 in total

1.  Platelet Na+, K+-ATPase activity as a possible peripheral marker for the neurotoxic effects of phenylalanine in phenylketonuria.

Authors:  M Bedin; C H Estrella; D V Duarte; D Ponzi; C S Dutra-Filho; A T Wyse; M Wajner; C M Wannmacher
Journal:  Metab Brain Dis       Date:  2000-06       Impact factor: 3.584

2.  Serum calcium levels in patients with essential hypertension and their first degree relatives.

Authors:  K Sudhakar; M Sujatha; S Ramesh Babu; P Padmavathi; P P Reddy
Journal:  Indian J Clin Biochem       Date:  2004-01

3.  Evaluation of serum magnesium differences in hypertensive crises and control patients: A randomly matched case-control study.

Authors:  IfeanyiChukwu O Onor; Emily K Johnston; Nicole G Little; Lashira M Hill; Oluwabunmi E Lawal; Casey J Payne; Mallory R Coleman; Carolkim H Huynh; Sarah E Bilbe; Ahlam A Ayyad; Kabrea J Jones; Jasmine D Kinnard; Rosanna Dastoori; Devinn K Rolland; Amanda S Miller; Robbie A Beyl; Christopher J Gillard; John I Okogbaa; Daniel F Sarpong; Rim M Hadgu; Amne Borghol; Samuel C Okpechi; Mihran V Naljayan; Shane E Sanne; Shane G Guillory
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-05-08       Impact factor: 3.738

4.  Blood pressure and levels of Fe, Ca, Mg, Zn, Cu, Na and K in the hair of young Bantu men from Tanzania.

Authors:  Ewa Rębacz-Maron; Irena Baranowska-Bosiacka; Izabela Gutowska; Dariusz Chlubek
Journal:  Biol Trace Elem Res       Date:  2013-01-03       Impact factor: 3.738

5.  Magnesium in disease.

Authors:  Helmut Geiger; Christoph Wanner
Journal:  Clin Kidney J       Date:  2012-02

6.  Serum calcium level in hypertension.

Authors:  Mohammed Abdul Hannan Hazari; Mehnaaz Sameera Arifuddin; Syed Muzzakar; Vontela Devender Reddy
Journal:  N Am J Med Sci       Date:  2012-11

7.  Evaluation of serum calcium differences in hypertensive crises and control patients: A randomly matched case-control study.

Authors:  IfeanyiChukwu O Onor; Rose M Duchane; Casey J Payne; Hannah Naquin Lambert; DeMaurian M Mitchner; Robbie A Beyl; Anh T Nguyen; Sarah E Bilbe; Andrea Arriaga White; Mariah W Johnson; Amber I Faciane; Emmanuel Kouagou; Stephanie A Hymel; Bria M Wates; Asia D Sanders; Phillip C B Vo; Jordan D Bates; Raven J Spooner; Christopher J Gillard; John I Okogbaa; Daniel F Sarpong; Rim M Hadgu; Samuel C Okpechi; Gabriel I Onor; Michael C Okoronkwo; Mihran V Naljayan; Shane G Guillory; Shane E Sanne
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-07-22       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.